• Acerca de la base de datos
  • ¿Cómo usar la IMDD?
  • Descargar la data
  • Preguntas frecuentes
  • Créditos
Vista de la lista Vista de las tarjetas
  • Dispositivo 12
  • Fabricante 10
  • Evento 124969
  • Implante 5
Retiro De Equipo (Recall) de Amplicor [3] AV-HRP. (Avidin-HRP (Horseradish Peroxidase) BGG Conju...
  • Tipo de evento
    Recall
  • ID del evento
    29566
  • Clase de Riesgo del Evento
    Class 2
  • Número del evento
    Z-1362-04
  • Fecha de inicio del evento
    2004-07-07
  • Fecha de publicación del evento
    2004-08-19
  • Estado del evento
    Terminated
  • País del evento
    United States
  • Fecha de finalización del evento
    2005-01-07
  • Fuente del evento
    USFDA
  • URL de la fuente del evento
    https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm?id=34124
  • Notas / Alertas
    U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
    The Parent Company was added by ICIJ.
    The parent company information is based on 2017 public records.
  • Notas adicionales en la data
    Assay,Hybridization And/Or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,Hepatitis C Virus - Product Code MZP
  • Causa
    An increased frequency of 'blue foci' that potentially can cause elevated a450 background in microwell plate wells after the addition of conjugate reagent during pcr detection.
  • Acción
    With respect to U.S distribution, email/letter on 6/24/04 to the local safety officers and general managers stationed at the affiliated distribution center, Roche Diagnostics Corporation of Indianapolis, IN. With respect to overseas distributors, email/letter on 6/24/04 to the local safety officers and general managers stationed at the affiliated distribution centers. Roche stated that the local safety officer is responsible to communicate the advisory both to the customers/end-users and the regulatory authority of the country. On July 6, 2004, a Revised Important Product Advice Notice was sent out to affiliates requiring the immediate discontinuation of the use of the affected kits, and destruction of any kits remaining in customers hands.
Retiro De Equipo (Recall) de Amplicor [3] AV-HRP. (Avidin-HRP (Horseradish Peroxidase) BGG Conju...
  • Tipo de evento
    Recall
  • ID del evento
    29566
  • Clase de Riesgo del Evento
    Class 2
  • Número del evento
    Z-1363-04
  • Fecha de inicio del evento
    2004-07-07
  • Fecha de publicación del evento
    2004-08-19
  • Estado del evento
    Terminated
  • País del evento
    United States
  • Fecha de finalización del evento
    2005-01-07
  • Fuente del evento
    USFDA
  • URL de la fuente del evento
    https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm?id=34125
  • Notas / Alertas
    U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
    The Parent Company was added by ICIJ.
    The parent company information is based on 2017 public records.
  • Notas adicionales en la data
  • Causa
    An increased frequency of 'blue foci' that potentially can cause elevated a450 background in microwell plate wells after the addition of conjugate reagent during pcr detection.
  • Acción
    With respect to U.S distribution, email/letter on 6/24/04 to the local safety officers and general managers stationed at the affiliated distribution center, Roche Diagnostics Corporation of Indianapolis, IN. With respect to overseas distributors, email/letter on 6/24/04 to the local safety officers and general managers stationed at the affiliated distribution centers. Roche stated that the local safety officer is responsible to communicate the advisory both to the customers/end-users and the regulatory authority of the country. On July 6, 2004, a Revised Important Product Advice Notice was sent out to affiliates requiring the immediate discontinuation of the use of the affected kits, and destruction of any kits remaining in customers hands.
Retiro De Equipo (Recall) de Device Recall Portex
  • Tipo de evento
    Recall
  • ID del evento
    29490
  • Clase de Riesgo del Evento
    Class 2
  • Número del evento
    Z-1299-04
  • Fecha de inicio del evento
    2004-07-02
  • Fecha de publicación del evento
    2004-07-30
  • Estado del evento
    Terminated
  • País del evento
    United States
  • Fecha de finalización del evento
    2006-05-02
  • Fuente del evento
    USFDA
  • URL de la fuente del evento
    https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm?id=34127
  • Notas / Alertas
    U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
    The Parent Company was added by ICIJ.
    The parent company information is based on 2017 public records.
  • Notas adicionales en la data
    Anesthesia Conduction Kit - Product Code CAZ
  • Causa
    Trays contain hospira recalled 2ml drug ampuls of 5% lidocaine hydrochloride with 7.5% dextrose injection, (ndc 0074-4712-01, lot number 09-568-dk) hospira, inc. was recalling the 2ml drug vials of 5% lidocaine hydrochloride w/ 7.5% dextrose lot number 09-568-dk). the drug is being recalled due to reports of particulate in the product.
  • Acción
    Smiths Medical notifed Dealers and direct customers were contacted via letter delivered by Federal Express on July 2, 2004. Customers and dealers are directed to fax back the attached Reply Letter
Retiro De Equipo (Recall) de Pacific Hemostasis D-Dimer Assay Kit, Fisher Diagnostics Catalog Num...
  • Tipo de evento
    Recall
  • ID del evento
    29573
  • Clase de Riesgo del Evento
    Class 3
  • Número del evento
    Z-1336-04
  • Fecha de inicio del evento
    2004-07-01
  • Fecha de publicación del evento
    2004-08-11
  • Estado del evento
    Terminated
  • País del evento
    United States
  • Fecha de finalización del evento
    2004-12-07
  • Fuente del evento
    USFDA
  • URL de la fuente del evento
    https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm?id=34141
  • Notas / Alertas
    U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
    The Parent Company was added by ICIJ.
    The parent company information is based on 2017 public records.
  • Notas adicionales en la data
    Fibrin Split Products - Product Code GHH
  • Causa
    Defective reagent may cause in vitro diagnostic test kit to yield false positive test results in clinical samples.
  • Acción
    The recalling firm notified consignees on 7/1/04 by letter flagged as a customer notification. The notice describes the potential for invalid control results using the speckled cards. The letter requests users to return the cards for replacement. Defective cards are described as isolated to those packaged in heat sealed cellophane type bags. The firm requests customers to return a response form with quantity needed for replacement.
Retiro De Equipo (Recall) de Device Recall Introducer guide
  • Tipo de evento
    Recall
  • ID del evento
    29574
  • Clase de Riesgo del Evento
    Class 3
  • Número del evento
    Z-0588-05
  • Fecha de inicio del evento
    2004-05-05
  • Fecha de publicación del evento
    2005-03-10
  • Estado del evento
    Terminated
  • País del evento
    United States
  • Fecha de finalización del evento
    2008-11-21
  • Fuente del evento
    USFDA
  • URL de la fuente del evento
    https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm?id=34142
  • Notas / Alertas
    U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
    The Parent Company was added by ICIJ.
    The parent company information is based on 2017 public records.
  • Notas adicionales en la data
    Catheter, Percutaneous - Product Code DQY
  • Causa
    The product is labeled as straight catheter but the package contains contralateral guide shaped catheters.
  • Acción
    A recall letter dated 04/30/2004 was sent to the consignees, instructing them to discontinue using the product and informed them that a Cordis representive would remove any unit in their possesion.
Retiro De Equipo (Recall) de Device Recall MammoTest System
  • Tipo de evento
    Recall
  • ID del evento
    29575
  • Clase de Riesgo del Evento
    Class 2
  • Número del evento
    Z-0379-05
  • Fecha de inicio del evento
    2004-07-09
  • Fecha de publicación del evento
    2005-01-05
  • Estado del evento
    Terminated
  • País del evento
    United States
  • Fecha de finalización del evento
    2012-03-13
  • Fuente del evento
    USFDA
  • URL de la fuente del evento
    https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm?id=34143
  • Notas / Alertas
    U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
    The Parent Company was added by ICIJ.
    The parent company information is based on 2017 public records.
  • Notas adicionales en la data
    System, X-Ray, Mammographic - Product Code IZH
  • Causa
    X-ray tube actuator shaft may fail, allowing the mechanism to drop without warning.
  • Acción
    Consignees were notified by letter on 7/9/2004.
Retiro De Equipo (Recall) de Device Recall Medikmark and Maxxim
  • Tipo de evento
    Recall
  • ID del evento
    29579
  • Clase de Riesgo del Evento
    Class 2
  • Número del evento
    Z-1136-04
  • Fecha de inicio del evento
    2004-07-12
  • Fecha de publicación del evento
    2004-07-22
  • Estado del evento
    Terminated
  • País del evento
    United States
  • Fecha de finalización del evento
    2006-06-27
  • Fuente del evento
    USFDA
  • URL de la fuente del evento
    https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm?id=34149
  • Notas / Alertas
    U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
    The Parent Company was added by ICIJ.
    The parent company information is based on 2017 public records.
  • Notas adicionales en la data
    Drape, Surgical - Product Code KKX
  • Causa
    The tip of the staple remover may puncture a hole in the wall of the tray, compromising the sterility of the kit.
  • Acción
    Recall notifications were sent by fax and follow-up registered mail to the direct account distributors and users on 7/12-15/04. The accounts were informed of the potential non-sterility of the product and were instructed to immediately discontinue sale/use of the products and place all inventory in quarantine pending return to Medikmark. Distributors were instructed to sub-recall the kits from their customers. Any questions were directed to 1-847-596-7723.
Retiro De Equipo (Recall) de Device Recall MediChoice
  • Tipo de evento
    Recall
  • ID del evento
    29579
  • Clase de Riesgo del Evento
    Class 2
  • Número del evento
    Z-1137-04
  • Fecha de inicio del evento
    2004-07-12
  • Fecha de publicación del evento
    2004-07-22
  • Estado del evento
    Terminated
  • País del evento
    United States
  • Fecha de finalización del evento
    2006-06-27
  • Fuente del evento
    USFDA
  • URL de la fuente del evento
    https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm?id=34150
  • Notas / Alertas
    U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
    The Parent Company was added by ICIJ.
    The parent company information is based on 2017 public records.
  • Notas adicionales en la data
    Drape, Surgical - Product Code KKX
  • Causa
    The tip of the staple remover may puncture a hole in the wall of the tray, compromising the sterility of the kit.
  • Acción
    Recall notifications were sent by fax and follow-up registered mail to the direct account distributors and users on 7/12-15/04. The accounts were informed of the potential non-sterility of the product and were instructed to immediately discontinue sale/use of the products and place all inventory in quarantine pending return to Medikmark. Distributors were instructed to sub-recall the kits from their customers. Any questions were directed to 1-847-596-7723.
Retiro De Equipo (Recall) de Device Recall MedikMark and Maxxim
  • Tipo de evento
    Recall
  • ID del evento
    29579
  • Clase de Riesgo del Evento
    Class 2
  • Número del evento
    Z-1138-04
  • Fecha de inicio del evento
    2004-07-12
  • Fecha de publicación del evento
    2004-07-22
  • Estado del evento
    Terminated
  • País del evento
    United States
  • Fecha de finalización del evento
    2006-06-27
  • Fuente del evento
    USFDA
  • URL de la fuente del evento
    https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm?id=34151
  • Notas / Alertas
    U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
    The Parent Company was added by ICIJ.
    The parent company information is based on 2017 public records.
  • Notas adicionales en la data
    Drape, Surgical - Product Code KKX
  • Causa
    The tip of the staple remover may puncture a hole in the wall of the tray, compromising the sterility of the kit.
  • Acción
    Recall notifications were sent by fax and follow-up registered mail to the direct account distributors and users on 7/12-15/04. The accounts were informed of the potential non-sterility of the product and were instructed to immediately discontinue sale/use of the products and place all inventory in quarantine pending return to Medikmark. Distributors were instructed to sub-recall the kits from their customers. Any questions were directed to 1-847-596-7723.
Retiro De Equipo (Recall) de Device Recall Express 2 Monorail
  • Tipo de evento
    Recall
  • ID del evento
    29581
  • Clase de Riesgo del Evento
    Class 1
  • Número del evento
    Z-1121-04
  • Fecha de inicio del evento
    2004-07-16
  • Fecha de publicación del evento
    2004-07-27
  • Estado del evento
    Terminated
  • País del evento
    United States
  • Fecha de finalización del evento
    2005-11-29
  • Fuente del evento
    USFDA
  • URL de la fuente del evento
    https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm?id=34159
  • Notas / Alertas
    U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
    The Parent Company was added by ICIJ.
    The parent company information is based on 2017 public records.
  • Notas adicionales en la data
    Stent, Coronary - Product Code MAF
  • Causa
    Due to characteristics in the delivery catheters that have the potential to impede balloon deflation during a coronary angioplasty procedure.
  • Acción
    Press release has been issued. Institutions with affected units will receive packages outlining the recall process and should immediately discontinue use of these units. Clinician and patient inquiries may be directed to Boston Scientific.
Retiro De Equipo (Recall) de Sheep Blood, Defibrinated - Catalog Number 212391, Unit 250 ml.
  • Tipo de evento
    Recall
  • ID del evento
    29531
  • Clase de Riesgo del Evento
    Class 3
  • Número del evento
    Z-1317-04
  • Fecha de inicio del evento
    2004-07-02
  • Fecha de publicación del evento
    2004-08-07
  • Estado del evento
    Terminated
  • País del evento
    United States
  • Fecha de finalización del evento
    2004-12-21
  • Fuente del evento
    USFDA
  • URL de la fuente del evento
    https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm?id=34163
  • Notas / Alertas
    U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
    The Parent Company was added by ICIJ.
    The parent company information is based on 2017 public records.
  • Notas adicionales en la data
    Culture Media, Antimicrobial Susceptibility Test, Excluding Mueller Hinton Agar - Product Code JSO
  • Causa
    Sheep blood products may be contaminated with a brucella species (b. ovis).
  • Acción
    Distributors were notified by fax, all customers were notified by fax with a UPS overnight delivery of hard copy of recall letter to same customers. BD International was notified be e-mail. Distributor fax indicated that BD required their customer lists immediately due to the nature of the recall event. BD received all Distributor customer lists on the same day (7/2/04). Will monitor the number of consignees non-responding to the recall through sending a letter that contains a form that we ask the end-user to return. Response forms will be reconciled. Distribution of the affected lots ceased on 7/1/04. Customers are asked to discard their inventory.
Retiro De Equipo (Recall) de Sheep Blood, Defibrinated - Catalog Number 212389, Unit 30 ml.
  • Tipo de evento
    Recall
  • ID del evento
    29531
  • Clase de Riesgo del Evento
    Class 3
  • Número del evento
    Z-1318-04
  • Fecha de inicio del evento
    2004-07-02
  • Fecha de publicación del evento
    2004-08-07
  • Estado del evento
    Terminated
  • País del evento
    United States
  • Fecha de finalización del evento
    2004-12-21
  • Fuente del evento
    USFDA
  • URL de la fuente del evento
    https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm?id=34164
  • Notas / Alertas
    U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
    The Parent Company was added by ICIJ.
    The parent company information is based on 2017 public records.
  • Notas adicionales en la data
    Culture Media, Antimicrobial Susceptibility Test, Excluding Mueller Hinton Agar - Product Code JSO
  • Causa
    Sheep blood products may be contaminated with a brucella species (b. ovis).
  • Acción
    Distributors were notified by fax, all customers were notified by fax with a UPS overnight delivery of hard copy of recall letter to same customers. BD International was notified be e-mail. Distributor fax indicated that BD required their customer lists immediately due to the nature of the recall event. BD received all Distributor customer lists on the same day (7/2/04). Will monitor the number of consignees non-responding to the recall through sending a letter that contains a form that we ask the end-user to return. Response forms will be reconciled. Distribution of the affected lots ceased on 7/1/04. Customers are asked to discard their inventory.
Retiro De Equipo (Recall) de Sheep Blood, Defibrinated - Catalog Number 211947, Unit 500 ml.
  • Tipo de evento
    Recall
  • ID del evento
    29531
  • Clase de Riesgo del Evento
    Class 3
  • Número del evento
    Z-1319-04
  • Fecha de inicio del evento
    2004-07-02
  • Fecha de publicación del evento
    2004-08-07
  • Estado del evento
    Terminated
  • País del evento
    United States
  • Fecha de finalización del evento
    2004-12-21
  • Fuente del evento
    USFDA
  • URL de la fuente del evento
    https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm?id=34165
  • Notas / Alertas
    U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
    The Parent Company was added by ICIJ.
    The parent company information is based on 2017 public records.
  • Notas adicionales en la data
    Culture Media, Antimicrobial Susceptibility Test, Excluding Mueller Hinton Agar - Product Code JSO
  • Causa
    Sheep blood products may be contaminated with a brucella species (b. ovis).
  • Acción
    Distributors were notified by fax, all customers were notified by fax with a UPS overnight delivery of hard copy of recall letter to same customers. BD International was notified be e-mail. Distributor fax indicated that BD required their customer lists immediately due to the nature of the recall event. BD received all Distributor customer lists on the same day (7/2/04). Will monitor the number of consignees non-responding to the recall through sending a letter that contains a form that we ask the end-user to return. Response forms will be reconciled. Distribution of the affected lots ceased on 7/1/04. Customers are asked to discard their inventory.
Retiro De Equipo (Recall) de Sheep Blood, Defibrinated - Catalog Number 211945, Unit 15 ml.
  • Tipo de evento
    Recall
  • ID del evento
    29531
  • Clase de Riesgo del Evento
    Class 3
  • Número del evento
    Z-1320-04
  • Fecha de inicio del evento
    2004-07-02
  • Fecha de publicación del evento
    2004-08-07
  • Estado del evento
    Terminated
  • País del evento
    United States
  • Fecha de finalización del evento
    2004-12-21
  • Fuente del evento
    USFDA
  • URL de la fuente del evento
    https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm?id=34169
  • Notas / Alertas
    U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
    The Parent Company was added by ICIJ.
    The parent company information is based on 2017 public records.
  • Notas adicionales en la data
    Culture Media, Antimicrobial Susceptibility Test, Excluding Mueller Hinton Agar - Product Code JSO
  • Causa
    Sheep blood products may be contaminated with a brucella species (b. ovis).
  • Acción
    Distributors were notified by fax, all customers were notified by fax with a UPS overnight delivery of hard copy of recall letter to same customers. BD International was notified be e-mail. Distributor fax indicated that BD required their customer lists immediately due to the nature of the recall event. BD received all Distributor customer lists on the same day (7/2/04). Will monitor the number of consignees non-responding to the recall through sending a letter that contains a form that we ask the end-user to return. Response forms will be reconciled. Distribution of the affected lots ceased on 7/1/04. Customers are asked to discard their inventory.
Retiro De Equipo (Recall) de Sheep Blood, Defibrinated - Catalog Number 212390, Unit 60 ml.
  • Tipo de evento
    Recall
  • ID del evento
    29531
  • Clase de Riesgo del Evento
    Class 3
  • Número del evento
    Z-1321-04
  • Fecha de inicio del evento
    2004-07-02
  • Fecha de publicación del evento
    2004-08-07
  • Estado del evento
    Terminated
  • País del evento
    United States
  • Fecha de finalización del evento
    2004-12-21
  • Fuente del evento
    USFDA
  • URL de la fuente del evento
    https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm?id=34170
  • Notas / Alertas
    U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
    The Parent Company was added by ICIJ.
    The parent company information is based on 2017 public records.
  • Notas adicionales en la data
    Culture Media, Antimicrobial Susceptibility Test, Excluding Mueller Hinton Agar - Product Code JSO
  • Causa
    Sheep blood products may be contaminated with a brucella species (b. ovis).
  • Acción
    Distributors were notified by fax, all customers were notified by fax with a UPS overnight delivery of hard copy of recall letter to same customers. BD International was notified be e-mail. Distributor fax indicated that BD required their customer lists immediately due to the nature of the recall event. BD received all Distributor customer lists on the same day (7/2/04). Will monitor the number of consignees non-responding to the recall through sending a letter that contains a form that we ask the end-user to return. Response forms will be reconciled. Distribution of the affected lots ceased on 7/1/04. Customers are asked to discard their inventory.
Retiro De Equipo (Recall) de MDA¿ Fibriquik¿, bioMeriux, Inc., Box 15969, Durham, North Carolina ...
  • Tipo de evento
    Recall
  • ID del evento
    30013
  • Clase de Riesgo del Evento
    Class 2
  • Número del evento
    Z-0053-05
  • Fecha de inicio del evento
    2004-08-20
  • Fecha de publicación del evento
    2004-10-28
  • Estado del evento
    Terminated
  • País del evento
    United States
  • Fecha de finalización del evento
    2005-06-09
  • Fuente del evento
    USFDA
  • URL de la fuente del evento
    https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm?id=35010
  • Notas / Alertas
    U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
    The Parent Company was added by ICIJ.
    The parent company information is based on 2017 public records.
  • Notas adicionales en la data
    Test, Thrombin Time - Product Code GJA
  • Causa
    Complaints were received from the field regarding prolonged clot times, high control values and erratic results.
  • Acción
    Consignees were notified by letter on 8/20/2004.
Retiro De Equipo (Recall) de BBL Brain Heart Infusion Agar w/10% Sheep Blood - Catalog Number 297...
  • Tipo de evento
    Recall
  • ID del evento
    29531
  • Clase de Riesgo del Evento
    Class 3
  • Número del evento
    Z-1322-04
  • Fecha de inicio del evento
    2004-07-02
  • Fecha de publicación del evento
    2004-08-07
  • Estado del evento
    Terminated
  • País del evento
    United States
  • Fecha de finalización del evento
    2004-12-21
  • Fuente del evento
    USFDA
  • URL de la fuente del evento
    https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm?id=34171
  • Notas / Alertas
    U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
    The Parent Company was added by ICIJ.
    The parent company information is based on 2017 public records.
  • Notas adicionales en la data
    Culture Media, Antimicrobial Susceptibility Test, Excluding Mueller Hinton Agar - Product Code JSO
  • Causa
    Sheep blood products may be contaminated with a brucella species (b. ovis).
  • Acción
    Distributors were notified by fax, all customers were notified by fax with a UPS overnight delivery of hard copy of recall letter to same customers. BD International was notified be e-mail. Distributor fax indicated that BD required their customer lists immediately due to the nature of the recall event. BD received all Distributor customer lists on the same day (7/2/04). Will monitor the number of consignees non-responding to the recall through sending a letter that contains a form that we ask the end-user to return. Response forms will be reconciled. Distribution of the affected lots ceased on 7/1/04. Customers are asked to discard their inventory.
Retiro De Equipo (Recall) de BBL TSA II w/5% Sheep Blood, Spacesaver - Catalog Number 292537.
  • Tipo de evento
    Recall
  • ID del evento
    29531
  • Clase de Riesgo del Evento
    Class 3
  • Número del evento
    Z-1323-04
  • Fecha de inicio del evento
    2004-07-02
  • Fecha de publicación del evento
    2004-08-07
  • Estado del evento
    Terminated
  • País del evento
    United States
  • Fecha de finalización del evento
    2004-12-21
  • Fuente del evento
    USFDA
  • URL de la fuente del evento
    https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm?id=34172
  • Notas / Alertas
    U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
    The Parent Company was added by ICIJ.
    The parent company information is based on 2017 public records.
  • Notas adicionales en la data
    Culture Media, Antimicrobial Susceptibility Test, Excluding Mueller Hinton Agar - Product Code JSO
  • Causa
    Sheep blood products may be contaminated with a brucella species (b. ovis).
  • Acción
    Distributors were notified by fax, all customers were notified by fax with a UPS overnight delivery of hard copy of recall letter to same customers. BD International was notified be e-mail. Distributor fax indicated that BD required their customer lists immediately due to the nature of the recall event. BD received all Distributor customer lists on the same day (7/2/04). Will monitor the number of consignees non-responding to the recall through sending a letter that contains a form that we ask the end-user to return. Response forms will be reconciled. Distribution of the affected lots ceased on 7/1/04. Customers are asked to discard their inventory.
Retiro De Equipo (Recall) de BBL Columbia C.N.A. Agar w/5% Sheep Blood/Levine EMB - Catalog Numb...
  • Tipo de evento
    Recall
  • ID del evento
    29531
  • Clase de Riesgo del Evento
    Class 3
  • Número del evento
    Z-1324-04
  • Fecha de inicio del evento
    2004-07-02
  • Fecha de publicación del evento
    2004-08-07
  • Estado del evento
    Terminated
  • País del evento
    United States
  • Fecha de finalización del evento
    2004-12-21
  • Fuente del evento
    USFDA
  • URL de la fuente del evento
    https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm?id=34173
  • Notas / Alertas
    U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
    The Parent Company was added by ICIJ.
    The parent company information is based on 2017 public records.
  • Notas adicionales en la data
    Culture Media, Antimicrobial Susceptibility Test, Excluding Mueller Hinton Agar - Product Code JSO
  • Causa
    Sheep blood products may be contaminated with a brucella species (b. ovis).
  • Acción
    Distributors were notified by fax, all customers were notified by fax with a UPS overnight delivery of hard copy of recall letter to same customers. BD International was notified be e-mail. Distributor fax indicated that BD required their customer lists immediately due to the nature of the recall event. BD received all Distributor customer lists on the same day (7/2/04). Will monitor the number of consignees non-responding to the recall through sending a letter that contains a form that we ask the end-user to return. Response forms will be reconciled. Distribution of the affected lots ceased on 7/1/04. Customers are asked to discard their inventory.
Retiro De Equipo (Recall) de Device Recall ARCHITECT
  • Tipo de evento
    Recall
  • ID del evento
    29587
  • Clase de Riesgo del Evento
    Class 3
  • Número del evento
    Z-1341-04
  • Fecha de inicio del evento
    2004-06-10
  • Fecha de publicación del evento
    2004-08-13
  • Estado del evento
    Terminated
  • País del evento
    United States
  • Fecha de finalización del evento
    2004-11-19
  • Fuente del evento
    USFDA
  • URL de la fuente del evento
    https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm?id=34174
  • Notas / Alertas
    U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
    The Parent Company was added by ICIJ.
    The parent company information is based on 2017 public records.
  • Notas adicionales en la data
    Electrode, Ion-Specific, Chloride - Product Code CGZ
  • Causa
    Process change in the manufacturing of the ac/dc driver board used on the analyzer may result in one or more of the solid state relays to fail during use.
  • Acción
    The firm initiated the recall by Technical Service Bulletin sent to affected customers. The AC/DC boards will be replaced on each analyzer by a firm representative.
Retiro De Equipo (Recall) de BBL Brain Heart Infusion Agar CC w/Sheep Blood - Catalog Number 296178.
  • Tipo de evento
    Recall
  • ID del evento
    29531
  • Clase de Riesgo del Evento
    Class 3
  • Número del evento
    Z-1325-04
  • Fecha de inicio del evento
    2004-07-02
  • Fecha de publicación del evento
    2004-08-07
  • Estado del evento
    Terminated
  • País del evento
    United States
  • Fecha de finalización del evento
    2004-12-21
  • Fuente del evento
    USFDA
  • URL de la fuente del evento
    https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm?id=34175
  • Notas / Alertas
    U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
    The Parent Company was added by ICIJ.
    The parent company information is based on 2017 public records.
  • Notas adicionales en la data
    Culture Media, Antimicrobial Susceptibility Test, Excluding Mueller Hinton Agar - Product Code JSO
  • Causa
    Sheep blood products may be contaminated with a brucella species (b. ovis).
  • Acción
    Distributors were notified by fax, all customers were notified by fax with a UPS overnight delivery of hard copy of recall letter to same customers. BD International was notified be e-mail. Distributor fax indicated that BD required their customer lists immediately due to the nature of the recall event. BD received all Distributor customer lists on the same day (7/2/04). Will monitor the number of consignees non-responding to the recall through sending a letter that contains a form that we ask the end-user to return. Response forms will be reconciled. Distribution of the affected lots ceased on 7/1/04. Customers are asked to discard their inventory.
Retiro De Equipo (Recall) de Device Recall Shiley TracheoSoft
  • Tipo de evento
    Recall
  • ID del evento
    29653
  • Clase de Riesgo del Evento
    Class 1
  • Número del evento
    Z-1312-04
  • Fecha de inicio del evento
    2004-07-08
  • Fecha de publicación del evento
    2004-08-07
  • Estado del evento
    Terminated
  • País del evento
    United States
  • Fecha de finalización del evento
    2005-11-29
  • Fuente del evento
    USFDA
  • URL de la fuente del evento
    https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm?id=34291
  • Notas / Alertas
    U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel data.
  • Notas adicionales en la data
    unknown device name - Product Code ---
  • Causa
    Device component can become disconnected or dislodged, leading to ineffective ventilation, which could result in serious injury or death.
  • Acción
    On 7/8/04, the firm initiated the recall. ***[After CDRH recommendations for class I recall situation, the firm issued PR via AP on 8/6/04.]*** .
Retiro De Equipo (Recall) de BBL Columbia C.N.A. Agar w/5% Sheep Blood - Catalog Number 297831.
  • Tipo de evento
    Recall
  • ID del evento
    29531
  • Clase de Riesgo del Evento
    Class 3
  • Número del evento
    Z-1326-04
  • Fecha de inicio del evento
    2004-07-02
  • Fecha de publicación del evento
    2004-08-07
  • Estado del evento
    Terminated
  • País del evento
    United States
  • Fecha de finalización del evento
    2004-12-21
  • Fuente del evento
    USFDA
  • URL de la fuente del evento
    https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm?id=34176
  • Notas / Alertas
    U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
    The Parent Company was added by ICIJ.
    The parent company information is based on 2017 public records.
  • Notas adicionales en la data
    Culture Media, Antimicrobial Susceptibility Test, Excluding Mueller Hinton Agar - Product Code JSO
  • Causa
    Sheep blood products may be contaminated with a brucella species (b. ovis).
  • Acción
    Distributors were notified by fax, all customers were notified by fax with a UPS overnight delivery of hard copy of recall letter to same customers. BD International was notified be e-mail. Distributor fax indicated that BD required their customer lists immediately due to the nature of the recall event. BD received all Distributor customer lists on the same day (7/2/04). Will monitor the number of consignees non-responding to the recall through sending a letter that contains a form that we ask the end-user to return. Response forms will be reconciled. Distribution of the affected lots ceased on 7/1/04. Customers are asked to discard their inventory.
Retiro De Equipo (Recall) de Device Recall AMATECH
  • Tipo de evento
    Recall
  • ID del evento
    29589
  • Clase de Riesgo del Evento
    Class 2
  • Número del evento
    Z-1327-04
  • Fecha de inicio del evento
    2004-07-12
  • Fecha de publicación del evento
    2004-08-07
  • Estado del evento
    Terminated
  • País del evento
    United States
  • Fecha de finalización del evento
    2005-05-05
  • Fuente del evento
    USFDA
  • URL de la fuente del evento
    https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm?id=34178
  • Notas / Alertas
    U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
    The Parent Company was added by ICIJ.
    The parent company information is based on 2017 public records.
  • Notas adicionales en la data
    Table, Operating-Room, Ac-Powered - Product Code FQO
  • Causa
    Neuro adapter may fail to engage and adequately clamp to the surgical table, resulting in movement.
  • Acción
    Allen Medical notified the two distributors by telephone on 7/12/04 and 7/16/04. A customer notifcation letter issued requesting return of the device for correction.
Retiro De Equipo (Recall) de Device Recall Webster Biosense
  • Tipo de evento
    Recall
  • ID del evento
    29591
  • Clase de Riesgo del Evento
    Class 2
  • Número del evento
    Z-1328-04
  • Fecha de inicio del evento
    2004-07-16
  • Fecha de publicación del evento
    2004-08-07
  • Estado del evento
    Terminated
  • País del evento
    United States
  • Fecha de finalización del evento
    2012-05-07
  • Fuente del evento
    USFDA
  • URL de la fuente del evento
    https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm?id=34180
  • Notas / Alertas
    U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
    The Parent Company was added by ICIJ.
    The parent company information is based on 2017 public records.
  • Notas adicionales en la data
    Catheter, Electrode Recording, Or Probe, Electrode Recording - Product Code DRF
  • Causa
    Generator failure resulting increase of catheter temperature that could not be controlled by power reduction.
  • Acción
    Customers were instructed to suspend use of the generators with software version 1.033 until they are upgraded with version 1.034B in a letter dated 7/15/2004. Firm issued a second letter on 9/17/04 for a software error discovered in-house during the upgrade. It instructs a workaround solution to prevent unwanted activity of the catheter.
  • « First
  • ‹ Prev
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • …
  • Next ›
  • Last »

Acerca de la base de datos

Explore más de 120,000 registros de retiros, alertas y notificaciones de seguridad de dispositivos médicos y sus conexiones con los fabricantes.

  • Preguntas frecuentes
  • Acerca de la base de datos
  • Contáctenos
  • Créditos

Historias en su correo

¿Trabaja en la industria médica? ¿O tiene experiencia con algún dispositivo médico? Nuestra reportería no ha terminado. Queremos oír de usted.

¡Cuéntanos tu historia!

Aviso

Los dispositivos médicos ayudan con el diagnóstico, la prevención y el tratamiento de muchas lesiones y enfermedades. A través de la International Medical Devices Database no estamos sugiriendo que compañías u otras entidades mencionadas en la base de datos hayan sido parte de una conducta ilegal o hayan actuado de manera impropia. Un mismo dispositivo médico puede tener distintos nombres en diferentes países. Esta base de datos no busca proporcionar asesoría médica. Los pacientes deben consultar con sus médicos para determinar si la data contiene información relevante y si la misma tiene implicaciones médicas para ellos.

Descargar la data

La International Medical Devices Database está bajo la licencia Open Database License y sus contenidos bajo la licencia Creative Commons Attribution-ShareAlike . Al usar esta data, siempre citar al International Consortium of Investigative Journalists. Puede descargar acá una copia de la base de datos.

Descargar todo (zipped)